Cover Image

Treatment of granulomatous perioral dermatitis with 1.5% topical ruxolitinib cream

Saved in:

Bibliographic Details
Main Authors:	Sophia S. Tran, BS (Author), Benjamin Ungar, MD (Author), Patrick M. Brunner, MD, MSc (Author)
Format:	Book
Published:	Elsevier, 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Granulomatous perioral dermatitis
by: Nadezhda V. Krasnova, et al.
Published: (2023)

The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
by: Deesha Desai, BS, et al.
Published: (2024)

Topical steroid withdrawal treated with ruxolitinib cream
by: Moira Shea, BS, et al.
Published: (2024)

Improvement of necrobiosis lipoidica with topical ruxolitinib cream after prior nonresponse to compounded topical tofacitinib cream
by: Shannon Nugent, BS, et al.
Published: (2022)

Treatment of cutaneous lupus with topical ruxolitinib cream
by: Jonathan J. Park, PhD, et al.
Published: (2022)

Delayed granulomatous eruption of the nose associated with ruxolitinib
by: Margaret Brown, MD, et al.
Published: (2020)

Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin
by: Donglin Zhang, BA, et al.
Published: (2023)

Ruxolitinib cream for the treatment of granuloma annulare
by: Austin J. Piontkowski, BS, et al.
Published: (2024)

Ruxolitinib cream for the treatment of cutaneous sarcoidosis
by: Jeffrey S. Smith, MD, PhD, et al.
Published: (2023)

Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis
by: Eleanor Pope, BA, et al.
Published: (2022)

Recalcitrant Hailey-Hailey disease successfully treated with topical ruxolitinib cream and dupilumab
by: Juna Khang, BA, et al.
Published: (2023)

Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication History
by: Andrew Blauvelt, et al.
Published: (2024)

Efficacy of topical ruxolitinib for cutaneous dermatomyositis
by: Aviya Lanis, MD, et al.
Published: (2024)

Letter in response to the case report "Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis"
by: Meron Teklu, MD, et al.
Published: (2023)

Recalcitrant lichen planus pigmentosus treated with topical ruxolitinib
by: Hannah L. Cornman, BS, et al.
Published: (2023)

Topical ruxolitinib for the treatment of granuloma faciale
by: Alan Wong, DO, et al.
Published: (2023)

Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives
by: Lawrence F. Eichenfield, et al.
Published: (2024)

Intractable chronic granulomatous perioral dermatitis in patients receiving growth hormone therapy: A new association between CGPD and GH
by: Ji Young Young, et al.
Published: (2020)

Porokeratoma treated with topical 5% 5-fluorouracil cream
by: Steve S. Li, BA, et al.
Published: (2021)

A Case of Perioral Dermatitis Successfully Treated with Abrocitinib
by: Teng Y, et al.
Published: (2023)

Educational Case: Granulomatous Dermatitis
by: Anne M. Stowman MD
Published: (2019)

Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
by: Paul Smith, et al.
Published: (2021)

Localized reactive granulomatous dermatitis secondary to erythema migrans
by: Dylan J. Badin, BS, et al.
Published: (2020)

Association of perioral dermatitis with facial mask usage during the COVID-19 pandemic: A retrospective study
by: William J. Nahm, BA, et al.
Published: (2023)

Infiltração Cutâneo-Mucosa Perioral / Perioral mucocutaneous infiltration
by: Mariana Batista, et al.
Published: (2018)

Penatalaksanaan Stomatitis Alergika Disertai Dermatitis Perioral Akibat Alergi Telur
by: Erna Sung, et al.
Published: (2017)

Perioral pigmentation
by: Siddharth Bhatt, et al.
Published: (2022)

Reactive granulomatous dermatitis: A useful and encompassing term
by: Karolyn Ann Wanat, MD, et al.
Published: (2022)

Designing a Topical Nanoliposomal Formulation of Ruxolitinib Phosphate
by: Atefeh Naeimifar, et al.
Published: (2023)

Reactive granulomatous dermatitis following COVID-19 vaccination
by: Grecia Figueroa-Ramos, MD, et al.
Published: (2024)

Palisaded neutrophilic granulomatous dermatitis: Spectrum of histologic findings in a single patient
by: Jessica E. Kalen, BS, et al.
Published: (2017)

Topical ruxolitinib 1.5% (JAK1/JAK2 inhibitor) improves clinical and patient‐reported outcomes in moderate to severe chronic hand dermatitis: Data from a small open‐label trial
by: Hannah D. Smith, et al.
Published: (2024)

Resolution of microneedling-associated granulomatous dermatitis with oral methotrexate
by: Elise D. Martin, MD, et al.
Published: (2021)

A case of interstitial granulomatous dermatitis presenting in a patient with necrotizing sarcoid granulomatosis
by: Rachel Elsanadi, BS, et al.
Published: (2023)

A Randomised Pilot Study on the Efficacy of Milking Cream and a Homeopathic Complex Topical Cream on Diaper Dermatitis
by: Janice Pellow, et al.
Published: (2013)

Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies
by: Eric L. Simpson, et al.
Published: (2024)

Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome
by: Christina Huang, BS, et al.
Published: (2023)

Development of sebaceous carcinoma in a patient on ruxolitinib therapy
by: Noreen Mohsin, BS, et al.
Published: (2022)

Abuse of topical steroid as cosmetic cream: A social background of steroid dermatitis
by: Rathi Sanjay
Published: (2006)

Tattoo pruritus successfully treated with ruxolitinib: A case series
by: Julianna Shin, BS, et al.
Published: (2024)